164 related articles for article (PubMed ID: 35506368)
21. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.
Zhou H; Jia X; Yang F; Shi P
Bioengineered; 2021 Dec; 12(1):6403-6417. PubMed ID: 34516354
[TBL] [Abstract][Full Text] [Related]
23. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia.
Shi X; Li J; Ma L; Wen L; Wang Q; Yao H; Ruan C; Wu D; Zhang X; Chen S
Oncol Lett; 2019 Jun; 17(6):4935-4947. PubMed ID: 31186703
[TBL] [Abstract][Full Text] [Related]
25. High bone marrow
Zhou JD; Ma JC; Zhang TJ; Li XX; Zhang W; Wu DH; Wen XM; Xu ZJ; Lin J; Qian J
Oncotarget; 2017 Nov; 8(54):91979-91989. PubMed ID: 29190891
[TBL] [Abstract][Full Text] [Related]
26. Revealing key lncRNAs in cytogenetically normal acute myeloid leukemia by reconstruction of the lncRNA-miRNA-mRNA network.
Sun T; Dong L; Guo Y; Zhao H; Wang M
Sci Rep; 2022 Mar; 12(1):4973. PubMed ID: 35322118
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia.
Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR
Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278
[TBL] [Abstract][Full Text] [Related]
28. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia.
Huang S; Lu B; Zhu M; Liu M; Sun Z; Pan X; Wei M
Expert Rev Hematol; 2022 Jul; 15(7):657-665. PubMed ID: 35713000
[TBL] [Abstract][Full Text] [Related]
30. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.
Zhou JD; Wen XM; Zhang YY; Yang L; Ma YJ; Ma JC; Yang J; Guo H; Yao DM; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(3):2384-91. PubMed ID: 26045745
[TBL] [Abstract][Full Text] [Related]
32. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of CD56 Antigen Expression in Patients with
Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J
Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
35. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
Zhang Y; Liu RY; Wang SJ; Wang C; Zhang QT; He C; Xie XS; Wan DM; Jiang ZX; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1880-1884. PubMed ID: 33283714
[TBL] [Abstract][Full Text] [Related]
37. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
38. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.
Wang YH; Lin CC; Hsu CL; Hung SY; Yao CY; Lee SH; Tsai CH; Hou HA; Chou WC; Tien HF
Ann Hematol; 2021 Feb; 100(2):487-498. PubMed ID: 33225420
[TBL] [Abstract][Full Text] [Related]
39. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
40. High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia.
Zhuang H; Li F; Si T; Pei R; Yu M; Chen D; Ye P; Lu Y
Acta Haematol; 2023; 146(3):196-205. PubMed ID: 36746134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
